Provistopto (Eye Drops, 5 mg/ml)

What Is Provistopto and What Is It Used For?

Provistopto is a prescription-only eye drop solution at a strength of 5 mg/ml, supplied in preservative-free single-dose containers. It is applied directly into the eye to treat the condition for which your doctor has prescribed it. The exact indication is determined individually and is described in the patient information leaflet supplied with your pack.

Provistopto belongs to the broad family of ophthalmic (eye) medications known as single-dose ophthalmic solutions. Prescription eye drops are an important part of modern ophthalmology because they deliver medicine directly to the tissues that need treatment — the ocular surface, the tear film, and in some cases the deeper structures of the eye — while keeping systemic exposure and whole-body side effects very low. This targeted, local delivery is particularly valuable when the underlying condition affects only the eye and the rest of the body does not need to be exposed to the drug.

The 5 mg/ml strength means that every millilitre of solution contains 5 milligrams of active substance. In practical terms, a typical eye drop is around 30–40 microlitres, so each individual drop contains a carefully measured small amount of medicine. The precise number of drops per day, how often they are applied, and for how long treatment is continued are all decided by your prescribing physician based on your specific diagnosis, the severity of the condition, your age, and your response to treatment.

Your doctor may prescribe Provistopto when they judge that the benefits of treatment outweigh the potential risks for your particular situation. Because indications and specific clinical uses are set out on a product-by-product basis by medicines regulators such as the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and national pharmacovigilance authorities, the authoritative source for the approved use of Provistopto is the patient information leaflet inside the carton you receive from the pharmacy. If anything in the leaflet is unclear, your pharmacist and prescribing physician are there to help.

Why Eye Drops Are Used

The eye is a remarkable but relatively isolated organ. Its surface is protected by the cornea, the tear film, and a blood–aqueous barrier that limits how easily substances from the bloodstream can reach the inside of the eye. Oral medicines often cannot achieve therapeutic concentrations at the ocular surface or inside the eye without producing unacceptable systemic side effects. Topical eye drops solve this problem by placing the drug exactly where it needs to act. Depending on the active substance, the effect can remain confined to the surface of the eye, or — for drugs designed to penetrate — reach the anterior chamber or other structures of the eye.

Your doctor will explain what Provistopto is meant to achieve in your case, how quickly you should expect to notice a change, and what signs would indicate that treatment is or is not working. Write down or remember the specific symptoms or measurements you and your doctor are monitoring so that you can report back accurately at your next appointment.

What Should You Know Before Using Provistopto?

Before the first use, tell your doctor about any allergies, other medicines (including other eye drops), other medical conditions, and whether you are pregnant, planning pregnancy, or breastfeeding. Read the patient information leaflet inside the pack and ask your pharmacist about anything you do not understand.

Contraindications

Do not use Provistopto if you are allergic (hypersensitive) to the active substance or to any of the other ingredients listed in the composition section of the patient information leaflet. An allergy to a component of a previous eye drop does not necessarily mean you will react to Provistopto, but it is important information for your doctor to weigh before prescribing. Signs of an allergic reaction to an eye drop can include marked redness and itching of the eye and eyelid that develop shortly after instillation, swelling of the eyelids, rash around the eye, or, in very rare cases, systemic symptoms such as generalized rash, facial swelling, or difficulty breathing.

Some eye drops also have specific clinical contraindications — conditions in which the risk of using the drop clearly outweighs any benefit. These are product-specific and are listed in Section 2 of the patient information leaflet supplied with your pack of Provistopto. Examples of contraindications that apply to many ophthalmic products include certain infections of the eye where a given mechanism of action could worsen disease, particular structural conditions of the eye, or the concurrent use of medicines that are known to interact dangerously. Your doctor will have checked for these when prescribing, but always double-check before the first use.

Warnings and Precautions

Several general precautions apply to virtually every prescription ophthalmic solution, including Provistopto:

• Use only as prescribed: Do not increase the number of drops, apply them more often than instructed, or continue treatment for longer than your doctor has said. More is not better with eye drops — extra medicine simply runs off the eye and increases the risk of side effects.
• Do not stop suddenly without advice: For some conditions, stopping eye drops abruptly can cause symptoms to rebound. If you feel you need to stop treatment for any reason, phone your doctor or pharmacist first.
• Tell your doctor about other eye drops: If you are using another eye drop — prescription or over-the-counter, including artificial tears — allow a gap of at least 5 to 10 minutes between different products so that the first drop has time to be absorbed before the next is instilled.
• Contact lenses: Most prescription eye drops should not be used while contact lenses are being worn unless your doctor specifically says otherwise. Remove contact lenses before instilling the drop and wait at least 15 minutes before reinserting them, unless the leaflet tells you differently.
• Children and adolescents: The safety and efficacy of many eye drops in children have not been established for every indication. Your doctor will have taken age into account when prescribing; always follow the regimen exactly.
• Damaged containers: Do not use any single-dose container that appears damaged, already opened, or whose outer pouch has been compromised.
• Report new symptoms: Any new eye pain, marked redness that does not settle, change in vision, or sensitivity to light that develops after starting Provistopto should be reported to your doctor promptly.

Pregnancy, Breastfeeding and Fertility

If you are pregnant, think you may be pregnant, or are planning to have a baby, tell your doctor before starting Provistopto. The same applies if you are breastfeeding. Although the total amount of medicine absorbed into the bloodstream from a drop placed on the eye is usually very small compared with oral or injected medicines, pregnancy and breastfeeding are situations where even small exposures must be weighed carefully. Your doctor will review the available evidence for the specific active substance in Provistopto and help you decide whether the expected benefit justifies use during pregnancy or lactation.

If pregnancy or breastfeeding is a possibility and your Provistopto pack is already in your home, do not start a new course without checking with your doctor or pharmacist first. For ongoing treatment started before pregnancy was identified, contact your doctor promptly — do not simply stop treatment, as stopping suddenly can itself cause problems depending on the condition being treated.

Driving and Operating Machinery

Like most eye drops, Provistopto can temporarily blur your vision immediately after instillation. This usually lasts a few minutes and resolves as the drop is cleared from the eye surface by blinking and natural tear flow. Do not drive, ride a bicycle, or operate machinery until your vision has fully returned to normal. If you experience any unusual visual symptoms — persistent blurring, double vision, halos around lights, or reduced vision that outlasts the immediate post-instillation period — stop driving and contact your doctor for advice.

Some eye drops can also cause a brief feeling of mild dizziness or lightheadedness because a small amount of the medicine is absorbed through the nasal mucosa after draining through the tear ducts. Gentle pressure over the inner corner of the eye for one to two minutes after instillation (punctal occlusion) helps reduce this systemic absorption.

How Does Provistopto Interact with Other Drugs?

Topical eye drops generally have limited systemic absorption, so whole-body drug interactions are much less frequent than with oral or injected medicines. However, you should still tell your doctor and pharmacist about every medicine you take, and especially about other eye drops, because local interactions on the eye surface are possible.

Because Provistopto is applied directly to the eye, most drug interactions of concern fall into two categories: local interactions at the ocular surface — where two topical products compete for contact time, alter each other's absorption, or together irritate the eye — and systemic interactions that can arise when the small amount of drug that passes into the bloodstream via the tear duct and nasal mucosa meets other medicines being taken orally or intravenously.

To let your doctor assess both kinds of interaction, make a complete list of every substance you take and bring it to your consultations. This list should include:

• All prescription medicines — oral tablets, capsules, liquids, patches, injections, inhalers, and other eye drops you currently use or have used in the last few weeks.
• Over-the-counter medicines — such as painkillers, cold remedies, antihistamines, and lubricating eye drops or artificial tears.
• Herbal and complementary products — plant extracts, vitamins, and dietary supplements can all interact with medicines.
• Recreational substances — tell your doctor honestly, because some substances can interact with eye medicines or affect vision independently.

Major Interactions

Major drug interactions with eye drops are those that could meaningfully increase the risk of side effects or reduce the effectiveness of either medicine. Because the specific active substance and the full list of medicines with which Provistopto is known to interact at a clinically significant level are product-specific, they are listed in the patient information leaflet you receive with the pack. If a community pharmacist flags a possible interaction when dispensing your prescription, take this seriously and, if necessary, phone the prescribing physician before starting the drops.

Minor Interactions

Minor interactions are those that are unlikely to cause significant harm but may reduce the comfort or the local effectiveness of the drop. The classic example is applying two different eye drops within seconds of each other: the second drop tends to wash away the first before the medicine has been absorbed into the ocular surface. Waiting at least five minutes — ten is even better — between any two different eye drops is a reliable rule of thumb that you can remember without a reference book.

What Is the Correct Dosage of Provistopto?

The correct dosage of Provistopto is the regimen your prescribing doctor has chosen for you, as stated on the prescription and in the patient information leaflet. This typically specifies how many drops, in which eye, how often per day, and for how long. Do not change the dose without medical advice.

Provistopto is a prescription-only medicine, and dosing is always individualized. The prescribing doctor considers multiple factors when choosing the regimen: the exact diagnosis, the severity and duration of the condition, the age and weight of the patient (particularly in children and elderly people), other medications being used, general health, and any coexisting eye conditions. For most prescription ophthalmic solutions, the dosage takes the form of a number of drops per eye at a fixed time interval — for example, one drop in the affected eye two or three times a day — continued for a defined treatment period.

Adults

For most adults, Provistopto will be prescribed as a specific number of drops instilled in the affected eye (or both eyes) at defined intervals during the day. Use the drops at evenly spaced times — for example, on waking and before bed for a twice-daily regimen, or morning, lunchtime, and evening for a three-times-daily regimen — to maintain a steady level of medicine on the eye surface throughout the day. Set phone alarms if the regimen is more than twice daily; it is easy to forget midday doses in a busy routine.

Children and Adolescents

Use of Provistopto in children and adolescents is decided on a case-by-case basis by a paediatrician or ophthalmologist. Many eye drops are formulated and studied primarily in adults, so additional caution is needed in paediatric use. If Provistopto has been prescribed for your child, an adult should always supervise or perform the administration. Keep a medication diary for children so you can track doses accurately and report clearly to the prescribing doctor at follow-up visits.

Elderly Patients

Age alone is rarely a reason to change the dose of a topical eye drop. However, older people are more likely to have reduced manual dexterity, tremor, or reduced vision, all of which can make self-administration harder. If you are finding it difficult to aim the drop correctly, several practical solutions can help: pharmacy-available bottle-aiming aids; administering drops while lying flat on a bed with the head on a pillow; or asking a family member or carer to help with the once-a-day or twice-a-day schedule. Report any difficulty to your doctor or pharmacist — a change to an easier-to-use preparation may sometimes be possible.

Missed Dose

If you realize you have missed a dose, instil the missed drop as soon as you remember — unless it is almost time for the next scheduled dose. In that case, skip the missed dose entirely and continue with your normal schedule. Never instil a double dose to make up for a missed one. Two drops instilled at the same time will not produce twice the effect because any excess simply overflows from the eye, but it may increase the risk of local side effects and, in some cases, systemic absorption.

Overdose

An overdose of an eye drop in the usual sense — too many drops placed in the eye — rarely causes harm, because the eye can only physically retain about one drop at a time; the rest overflows onto the cheek. However, if a child accidentally drinks from a bottle or swallows the contents of multiple single-dose containers, or if a very large amount is inadvertently systemically absorbed, contact your national poison control center, emergency services, or local emergency department immediately. Keep the packaging with you so that healthcare professionals can identify the exact preparation, strength, and excipients. In Europe the universal emergency number is 112; in the United States it is 911; the Poison Control hotline in the U.S. is 1-800-222-1222.

What Are the Side Effects of Provistopto?

Like all medicines, Provistopto can cause side effects, although not everyone experiences them. Local reactions at the eye surface are the most commonly reported. The complete list of reported adverse reactions specific to your product is in the patient information leaflet inside the pack.

Adverse reactions reported with prescription eye drops generally fall into local (eye-related), allergic, and systemic categories. For products in single-dose preservative-free containers, many of the classical chronic irritation symptoms linked to preservatives are reduced, but local reactions to the active substance itself, to other excipients, or simply to the mechanical act of instilling the drop can still occur. The categories below describe the types of reactions commonly seen with ophthalmic solutions in general; the frequency of each reaction specifically with Provistopto is provided in the patient information leaflet, using the standard EMA frequency categories.

It is important to distinguish between a brief, self-limiting stinging sensation when the drop first touches the eye — which is very common with most eye drops and typically resolves within seconds — and a persistent, spreading, or painful reaction that lasts or intensifies over time. The former is an expected instillation effect that does not usually need medical attention; the latter should always be reported promptly to your doctor.

Reporting Side Effects

Reporting suspected side effects after a medicine has been authorized is important. It allows continuous monitoring of the benefit–risk balance of the medicine and helps regulators detect new or rare reactions that did not appear in pre-marketing clinical trials. Healthcare professionals and patients can both report suspected adverse reactions:

• In the European Union, reports can be submitted through the national reporting systems of each member state. A list of reporting systems is available via the European Medicines Agency (EMA) website.
• In the United States, adverse events can be reported to the FDA's MedWatch program at the FDA website or by phone.
• In the United Kingdom, reports are submitted through the MHRA Yellow Card Scheme.
• In other countries, your national medicines regulator or pharmacovigilance center will have a patient reporting form, usually online.

When reporting, include as much detail as you can: the name Provistopto, the strength (5 mg/ml), the batch number (printed on the carton and single-dose container), the date you started and stopped treatment, the reaction you experienced, and the outcome. Your report helps protect other patients.

How Should You Store Provistopto?

Store Provistopto according to the instructions printed on the outer carton and in the patient information leaflet. Keep single-dose containers in their original packaging to protect them from light until use. Keep out of the sight and reach of children. Do not use after the expiry date.

Proper storage is essential for any sterile ophthalmic product. Small changes in temperature, light exposure, or packaging integrity can affect both the potency of the active ingredient and the sterility of the solution. The specific storage conditions for Provistopto — for example, whether it should be kept below a particular temperature, away from direct light, or refrigerated after first opening of the outer foil pouch — are printed on the carton and in the patient information leaflet. The following general principles apply:

• Temperature: Do not expose eye drops to extreme heat or cold. Most ophthalmic solutions are stored at or below room temperature (for example, below 25 °C / 77 °F). Do not freeze unless specifically instructed. Do not leave Provistopto on a sunny window ledge or inside a parked car on a hot day.
• Light protection: Keep the single-dose containers in the original outer pouch and carton to protect them from light until you are ready to use them.
• Children: Keep Provistopto out of the sight and reach of children. Single-dose containers are small and can be mistaken for other household items; an accidental ingestion should be treated as a potential poisoning.
• Expiry date: Do not use after the expiry date printed on the carton and the individual container (usually shown as "EXP" followed by a month and year). The expiry date refers to the last day of the indicated month.
• Single-use only: Each single-dose container is intended for one administration only and must be discarded immediately after use, even if some solution remains. Reusing an opened container risks introducing bacteria into the eye.
• Pouch stability: Once the outer aluminium pouch is opened (where applicable), any remaining single-dose containers should be used within the period stated in the patient information leaflet.
• Disposal: Do not dispose of medicines in wastewater or household waste. Return unused or expired medicines to a pharmacy for safe disposal in accordance with local regulations. This protects the environment by preventing pharmaceutical residues from reaching waterways.

Check each single-dose container visually before use. The solution should be clear and free of visible particles, the container tip should be intact, and the container itself should not show signs of damage or leakage. If you have any doubt about the quality of a container, do not use it and ask your pharmacist for advice.

What Does Provistopto Contain?

Provistopto contains the active substance at 5 mg/ml as its therapeutic ingredient, together with a small set of excipients that form a sterile, preservative-free ophthalmic solution. The complete list of ingredients is in Section 6 of the patient information leaflet inside the pack.

Understanding the full composition of an eye drop matters for two reasons. First, a small proportion of people have allergies or sensitivities to specific excipients (for example, phosphates, sulfites, or specific polymers) that can cause reactions even though the active substance itself is well tolerated. Second, some excipients have clinically relevant properties of their own — for example, they may act as viscosity modifiers that extend contact time on the eye, as buffers that keep the pH compatible with the tear film, or as osmotic agents that bring the solution close to the natural osmolality of tears.

Active Ingredient

Active substance: 5 mg per millilitre of solution. Because Provistopto is a prescription-only preparation, the full monograph of the active substance, including its mechanism of action and pharmacokinetic properties, is held by the national medicines regulator that approved the product. Your pharmacist can provide additional technical information if you ask.

Inactive Ingredients (Excipients)

Because Provistopto is supplied in preservative-free single-dose containers, it does not require a preservative such as benzalkonium chloride. This is particularly valuable for patients who will use multiple drops per day over prolonged periods or who have underlying dry eye disease, because preservatives can contribute to ocular surface irritation with long-term exposure. The preservative-free design is one of the advantages of single-dose packaging and is a reason eye care specialists often prefer it for sensitive eyes.

Physical Characteristics and Pack Presentation

Provistopto is supplied as a clear solution in small plastic single-dose containers, typically grouped in aluminium pouches that protect them from light and moisture until use. A carton commonly contains multiple pouches, and each pouch contains several single-dose containers. Pack size information — for example, how many containers per pack are available in your country — is stated on the outer carton. Not every pack size may be marketed in every country; your local pharmacy will dispense the pack that matches your prescription.

How to Use Provistopto Correctly

Clean hands, one single-dose container, correct head position, no contact between the container tip and the eye, gentle closure of the eye for 1–2 minutes with pressure on the inner corner to reduce systemic absorption, and immediate disposal of the container after use.

How you apply Provistopto has a direct impact on how well the medicine works. Many patients receive a prescription without ever being shown good technique, and studies in The British Journal of Ophthalmology and Eye (Nature) have shown that a significant proportion of patients consistently miss the eye entirely, apply more drops than needed, or contaminate the container tip. The seven steps below cover the essentials for any single-dose eye drop, including Provistopto:

1. Prepare: Wash your hands thoroughly with soap and water and dry them with a clean towel. Remove contact lenses if you wear them, unless the leaflet specifically says otherwise.
2. Open the pouch: Tear open the aluminium pouch, take out one single-dose container, and reseal the pouch to protect any remaining containers. Check that the container is intact and the solution is clear.
3. Open the container: Hold the container upright and twist off the small tab or cap. Do not touch the tip or set it down on a surface.
4. Position yourself: Tilt your head back and look up, or lie down on a bed looking at the ceiling. Gently pull down the lower eyelid with a clean finger to form a small pocket between the eye and the eyelid.
5. Instil the drop: Hold the container above the eye, close to but not touching the eye or eyelid, and gently squeeze to release one drop into the pocket formed by the lower eyelid. Avoid blinking during instillation.
6. Close and press: Close the eye gently (do not squeeze) for one to two minutes. With a clean finger, apply light pressure to the inner corner of the eye, near the nose, to close the tear duct. This reduces the amount of medicine that drains into the nose and is systemically absorbed.
7. Discard: Throw away the single-dose container immediately, even if some solution remains. Do not keep it for later use. Wash your hands again.

If your prescription calls for drops in both eyes, repeat the process with a new single-dose container for the second eye. Do not use one container for both eyes, as this defeats the purpose of the preservative-free single-dose presentation and risks transferring infection between eyes.

Frequently Asked Questions About Provistopto